Limpatricia (Talk | contribs) |
|||
Line 20: | Line 20: | ||
<h2>Aim</h2> | <h2>Aim</h2> | ||
− | <p>The objective of our project was to genetically engineer <i>E. coli</i> to produce PHB from volatile fatty acids (VFAs) found in human fecal waste. VFAs (acetic acid, propionic acid, butyric acid, and lactic acid) serve as | + | <p>The objective of this part of our project was to genetically engineer <i>E. coli</i> to produce PHB from volatile fatty acids (VFAs) found in human fecal waste. VFAs (acetic acid, propionic acid, butyric acid, and lactic acid) serve as precursors for the synthesis of PHB via the beta-oxidation pathway native to bacterial cells (Reyhanitash, 2017).</p> |
− | <p>In order to synthesize PHB from fatty acids found in human fecal waste, we manipulated the fatty acid beta-oxidation pathway within <i>E. coli</i>. | + | |
+ | <p>In order to synthesize PHB from fatty acids found in human fecal waste, we manipulated the fatty acid beta-oxidation pathway within <i>E. coli</i>. We designed a construct that contains the <i>phaJ4</i> gene from <i><i>Pseudomonas putida</i>, encoding for enoyl-CoA hydratase that converts the enoyl-CoA into (R)-hydroxybutyrate (Lu, 2003). Our construct also includes the <i>phaC1</i> gene from <i>Pseudomonas aeruginosa</i>, encoding the PHA synthase, which converts the (R)-hydroxyacyl-CoA into polyhydroxybutyrate (PHB). To our advantage, this pathway not only uses VFAs, but can also use undigested long-chain fatty acids in human fecal waste, thus maximizing the substrates available for PHB synthesis.</p> | ||
<br> | <br> | ||
Line 36: | Line 37: | ||
<p><center><img src="https://static.igem.org/mediawiki/2017/7/75/Calgary2017_BetaOxidationConstruct.png" alt="Beta-Oxidation Construct" style="width:100%"></center></p> | <p><center><img src="https://static.igem.org/mediawiki/2017/7/75/Calgary2017_BetaOxidationConstruct.png" alt="Beta-Oxidation Construct" style="width:100%"></center></p> | ||
− | <p><center>Figure 1: Genetic construct for phaCJ, including the ribosomal binding sites (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and the phaJ and phaC genes</center></p> | + | <p><center>Figure 1: Genetic construct for phaCJ, including the ribosomal binding sites (<a href="http://parts.igem.org/Part:BBa_B0034">BBa_B0034</a>) and the <i>phaJ</i> and <i>phaC</i> genes</center></p> |
<p> | <p> | ||
Line 45: | Line 46: | ||
<h2>Results</h2> | <h2>Results</h2> | ||
− | + | Subcultures of <i>E. coli</i> BL21(DE3) were grown in 60 mL of various types media for 24 hours. Cultures were then induced with 0.1 mM IPTG to express <i>phaC1</i> and <i>phaJ4</i>. Cultures were incubated for 24 hours and OD<sub>600</sub> was measured. Absorbance was adjusted by diluting cultures with LB so they were all between 0.4-0.6, and nutrients and substrates were added to the flasks to allow for PHB production. The composition of each test culture is shown below:</p> | |
<table> | <table> | ||
<tr> | <tr> | ||
− | <th><b>Glucose ( | + | <th><b><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control)</b></th> |
− | <th><b>pET29B in | + | <th><b><i>E. coli</i> BL21(DE3) with pET29B(+) in LB Media (negative control)</b></th> |
</tr> | </tr> | ||
<tr> | <tr> | ||
<td> | <td> | ||
<ul> | <ul> | ||
− | <li> 10 ml | + | <li> 10 ml of culture in LB+Kanamycin</li> |
<li> 7 ml 20% Glucose </li> | <li> 7 ml 20% Glucose </li> | ||
<li> 100 uL MgSO<sub>4</sub></li> | <li> 100 uL MgSO<sub>4</sub></li> | ||
Line 65: | Line 66: | ||
<td> | <td> | ||
<ul> | <ul> | ||
− | <li> 10 ml | + | <li> 10 ml of culture in LB+Kanamycin</li> |
<li> "Syn poo" fermented supernatant </li> | <li> "Syn poo" fermented supernatant </li> | ||
<li> 100 uL MgSO<sub>4</sub></li> | <li> 100 uL MgSO<sub>4</sub></li> | ||
Line 74: | Line 75: | ||
</td> | </td> | ||
</tr> | </tr> | ||
− | <tr><th><b>Fermented " | + | <tr><th><b><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs</b></th> |
− | <th><b>Pure VFAs</b></th></tr> | + | <th><b><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Pure VFAs</b></th></tr> |
<tr> | <tr> | ||
<td> | <td> | ||
<ul> | <ul> | ||
− | <li> 10 ml | + | <li> 10 ml of culture in LB+Kanamycin</li> |
− | <li> 10 ml | + | <li> 10 ml Syn Poo fermented supernatant</li> |
<li> 100 uL MgSO<sub>4</sub></li> | <li> 100 uL MgSO<sub>4</sub></li> | ||
<li> 5 uL CaCl<sub>2</sub></li> | <li> 5 uL CaCl<sub>2</sub></li> | ||
Line 90: | Line 91: | ||
<td> | <td> | ||
<ul> | <ul> | ||
− | <li> 10 ml | + | <li> 10 ml of culture in LB+Kanamycin</li> |
<li> VFAs | <li> VFAs | ||
<ul> | <ul> | ||
Line 110: | Line 111: | ||
<p> | <p> | ||
− | The OD<sub>600</sub> readings of .....???? were | + | Three replicates of each growth condition were performed. The OD<sub>600</sub> readings of .....???? were recorded: |
<table> | <table> | ||
<tr> | <tr> | ||
Line 119: | Line 120: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+) in LB Media (negative control)</td> |
<td>0.571</td> | <td>0.571</td> | ||
<td>0.531</td> | <td>0.531</td> | ||
Line 125: | Line 126: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Glucose ( | + | <td>E. coli</i> BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control)</td> |
<td>0.190</td> | <td>0.190</td> | ||
<td>0.195</td> | <td>0.195</td> | ||
Line 131: | Line 132: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Pure VFAs</td> | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Pure VFAs</td> |
<td>0.140</td> | <td>0.140</td> | ||
<td>0.134</td> | <td>0.134</td> | ||
Line 137: | Line 138: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Fermented " | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs</td> |
<td>0.135</td> | <td>0.135</td> | ||
<td>0.107</td> | <td>0.107</td> | ||
Line 145: | Line 146: | ||
</p> | </p> | ||
− | <p> After | + | <p> After pelleting the cultures, the cells were resuspended in 1 x PBS. The OD<sub>600</sub> readings were taken: |
<table> | <table> | ||
<tr> | <tr> | ||
Line 154: | Line 155: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td> | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+) in LB Media (negative control)</td> |
<td>2.659</td> | <td>2.659</td> | ||
<td>2.001</td> | <td>2.001</td> | ||
Line 160: | Line 161: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Glucose ( | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control)</td> |
<td>1.934</td> | <td>1.934</td> | ||
<td>1.887</td> | <td>1.887</td> | ||
Line 166: | Line 167: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Pure VFAs</td> | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Pure VFAs</td> |
<td>0.510</td> | <td>0.510</td> | ||
<td>0.571</td> | <td>0.571</td> | ||
Line 172: | Line 173: | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | <td>Fermented " | + | <td><i>E. coli</i> BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs</td> |
<td>2.533</td> | <td>2.533</td> | ||
<td>2.559</td> | <td>2.559</td> | ||
Line 183: | Line 184: | ||
<h2>Future Directions</h2> | <h2>Future Directions</h2> | ||
− | <p>We would like to maximize the amount of PHB produced with our construct by upregulating the genes <i>fadE</i> and <i>fadD</i> upstream of the beta-oxidation cycle. This may produce more | + | <p>We would like to maximize the amount of PHB produced with our construct by upregulating the genes <i>fadE</i> and <i>fadD</i> upstream of the beta-oxidation cycle. This may produce more substrates for <i>phaJ</i> and <i>phaC</i> to convert into PHB. |
− | <p>We would also test out the effects of using a constitutive promoter.</p> | + | <p>We would also like to test out the effects of using a constitutive promoter and compare it to the use of our IPTG-inducible T7 promoter.</p> |
<br> | <br> |
Revision as of 08:05, 31 October 2017
Beta Oxidation
Aim
The objective of this part of our project was to genetically engineer E. coli to produce PHB from volatile fatty acids (VFAs) found in human fecal waste. VFAs (acetic acid, propionic acid, butyric acid, and lactic acid) serve as precursors for the synthesis of PHB via the beta-oxidation pathway native to bacterial cells (Reyhanitash, 2017).
In order to synthesize PHB from fatty acids found in human fecal waste, we manipulated the fatty acid beta-oxidation pathway within E. coli. We designed a construct that contains the phaJ4 gene from Pseudomonas putida, encoding for enoyl-CoA hydratase that converts the enoyl-CoA into (R)-hydroxybutyrate (Lu, 2003). Our construct also includes the phaC1 gene from Pseudomonas aeruginosa, encoding the PHA synthase, which converts the (R)-hydroxyacyl-CoA into polyhydroxybutyrate (PHB). To our advantage, this pathway not only uses VFAs, but can also use undigested long-chain fatty acids in human fecal waste, thus maximizing the substrates available for PHB synthesis.
Volatile fatty acids & beta-oxidation pathway
…
Genetic construct
…
Results
Subcultures of E. coli BL21(DE3) were grown in 60 mL of various types media for 24 hours. Cultures were then induced with 0.1 mM IPTG to express phaC1 and phaJ4. Cultures were incubated for 24 hours and OD600 was measured. Absorbance was adjusted by diluting cultures with LB so they were all between 0.4-0.6, and nutrients and substrates were added to the flasks to allow for PHB production. The composition of each test culture is shown below:E. coli BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control) | E. coli BL21(DE3) with pET29B(+) in LB Media (negative control) |
---|---|
|
|
E. coli BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs | E. coli BL21(DE3) with pET29B(+)-phaJC + Pure VFAs |
|
|
Three replicates of each growth condition were performed. The OD600 readings of .....???? were recorded:
Condition | OD600 of replicate 1 | OD600 of replicate 2 | OD600 of replicate 3 |
---|---|---|---|
E. coli BL21(DE3) with pET29B(+) in LB Media (negative control) | 0.571 | 0.531 | 0.487 |
E. coli BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control) | 0.190 | 0.195 | 0.139 |
E. coli BL21(DE3) with pET29B(+)-phaJC + Pure VFAs | 0.140 | 0.134 | 0.146 |
E. coli BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs | 0.135 | 0.107 | 0.144 |
After pelleting the cultures, the cells were resuspended in 1 x PBS. The OD600 readings were taken:
Condition | OD600 of replicate 1 | OD600 of replicate 2 | OD600 of replicate 3 |
---|---|---|---|
E. coli BL21(DE3) with pET29B(+) in LB Media (negative control) | 2.659 | 2.001 | 2.899 |
E. coli BL21(DE3) with pET29B(+)-phaJC in Glucose (positive control) | 1.934 | 1.887 | 1.919 |
E. coli BL21(DE3) with pET29B(+)-phaJC + Pure VFAs | 0.510 | 0.571 | 0.532 |
E. coli BL21(DE3) with pET29B(+)-phaJC + Fermented "Syn Poo" Supernatant Containing Glucose and VFAs | 2.533 | 2.559 | 2.349 |
Future Directions
We would like to maximize the amount of PHB produced with our construct by upregulating the genes fadE and fadD upstream of the beta-oxidation cycle. This may produce more substrates for phaJ and phaC to convert into PHB.
We would also like to test out the effects of using a constitutive promoter and compare it to the use of our IPTG-inducible T7 promoter.
Works Cited
Lu, X., Zhang, J., Wu, Q. & Chen, G.Q. (2003) Enhanced production of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) via manipulating the fatty acid beta-oxidation pathway in E. coli. FEMS Microbiol Lett. 221: 97-101.
Reyhanitash, E., Kersten, S. & Schuur, B. (2017) Recovery of volatile fatty acids from fermented wastewater by adsorption. ACS sustainable Chemical Engineering. 5: 9176-9184.
Rose, C., Parker, A., Jefferson, B. & Cartmell, E. (2015). The characterization of feces and urine: a review of the literature to informed advanced treatment technology. Critical Reviews in Environmental Science Technology. 45: 1827-1879.